医療用ポイントオブケア

ソリューション

The rise of point-of-care technologies has enabled more testing and diagnosis close to the patient, increasing effectiveness and success rates. Advances in medical testing (blood glucose, oxygen saturation, rapid strep, etc.) and minimally to non-invasive genomic diagnoses like liquid biopsies have improved point-of-care diagnostics and made treatment more accessible.

Over the last several decades, onsemi has built a vast portfolio of intellectual property in medical applications, both internally and through partnerships with healthcare, imaging, and medical device manufacturers. Our customers depend on our product longevity spanning the entire product lifecycle, which can span decades. We meet stringent quality requirements through our world-class manufacturing facilities, offering ISO 13485 certification and FDA compliance.